Pseudomembranous colitis is an inflammatory disease of the colon that most often occurs due to colonization of the intestine by microorganisms of the Clostridium family, in particular Clostridium difficile. This condition often develops in patients receiving antibiotic therapy, which leads to an imbalance in the intestinal microflora and, as a result, excessive growth of pathogenic symbionts. The main clinical manifestations of pseudomembranous colitis are diarrhea, abdominal pain, fever, and, in severe cases, manifestations of toxic megacolon. However, timely diagnosis and proper treatment can effectively control the disease and prevent serious complications.
History of the disease and interesting historical facts
Pseudomembranous colitis was first described in detail in 1978, when researchers noted a link between antibiotic therapy and the development of inflammatory bowel disease. Initially, the disease was associated with the use of antibiotics and their effect on the normal intestinal microflora. Over time, certain factors that contribute to the development of this pathology became known. In the 1980s, a large number of outbreaks of pseudomembranous colitis occurred in hospitals, which led to more in-depth research and strengthening the concept of Clostridium difficile as the etiologic agent of this pathology. Equally interesting is the fact that with each passing decade, the incidence of tadisease has increased, which emphasizes the importance of recognizing this condition as a significant public health problem.
Epidemiology
Epidemiological studies show that pseudomembranous colitis has become the most common intestinal infection in hospital settings in recent years. It is estimated that approximately 10–25% patients receiving systemic antibiotic therapy may develop pseudomembranous colitis. In some areas, the incidence of this condition is increasing, particularly in patients over 65 years of age. According to the Centers for Disease Control and Prevention (CDC), there are more than 450,000 hospitalizations associated with Clostridium difficile in the United States, indicating the significance of this problem.
Genetic predisposition to this disease
Currently, studies of genetic predisposition to pseudomembranous colitis are under active study. Scientists suggest that certain polymorphisms of genes associated with the immune response and microbiota may be involved in the development of this pathology. For example, gene mutations affecting the production of proinflammatory cytokines may increase the risk of inflammatory bowel diseases. However, despite the identified associations, genetic predisposition is still overstudied, and further clinical studies are needed to better understand the role of genetics in the pathogenesis of pseudomembranous colitis.
Risk factors for the development of this disease
The main risk factors that contribute to the development of pseudomembranous colitis include:
- Taking antibiotics, especially broad-spectrum ones
- Old age, in particular over 65 years
- The presence of comorbidities such as diabetes, kidney disease or immunodeficiency
- Long stays in hospitals or medical institutions
- Bowel surgery
- History of relapses of the disease
Chemical factors such as long-term use of proton pump inhibitors also play a significant role in the development of the disease.
Diagnosis of this disease
Diagnosis of pseudomembranous colitis includes the following sequence of actions:
- Assessing key symptoms such as diarrhea, abdominal pain, fever and mucus in the stool.
- Laboratory tests, including stool testing for Clostridium difficile toxins or detection of its DNA by PCR.
- Radiological tests such as CT scan of the abdomen to look for thickening of the bowel wall or signs of toxic megacolon.
- Colonoscopy, which may show pseudomembranous changes in the mucosa.
A careful differential diagnosis with other forms of colitis, such as ulcerative colitis or painful colitis, should also be performed to exclude concomitant diseases.
Treatment
Treatment of pseudomembranous colitis should be individualized and may include the following approaches:
- General treatment: discontinuing the antibiotics that caused the disease is the first step.
- Pharmacologic treatment: use of antibiotics such as metronidazole or vancomycin to suppress Clostridium difficile.
- Surgery: In severe cases, surgery may be required to remove affected areas of the intestine.
- Other treatments include using probiotics and fecal transplants to restore normal gut flora.
List of medications used to treat this disease
- Metronidazole
- Vancomycin
- Fidacosicin
- Probiotics (eg, Saccharomyces boulardii)
Disease monitoring
Monitoring of patients with pseudomembranous colitis includes monitoring of clinical symptoms, repeated Clostridium difficile testing, and assessment of overall bowel function. It is important to understand that the risk of relapse remains after completion of treatment, so regular monitoring is necessary for several months after completion of therapy. The prognosis of the disease is generally favorable with timely diagnosis and adequate treatment. Complications such as toxic megacolon or intestinal perforation can lead to serious consequences and require urgent intervention.
Age-related features of the disease
Pseudomembranous colitis can occur in different age groups, but its incidence increases with age. In older people, the condition may be more severe due to the presence of concomitant diseases and decreased immunity. In children, the disease is less common and is often associated with the use of antibiotics. However, in young people and infants, pseudomembranous colitis may manifest itself in a milder form, although it also requires attention and professional help.
Questions and Answers
- What are the main symptoms of pseudomembranous colitis? The main symptoms are diarrhea, abdominal pain, fever and the presence of mucus in the stool.
- How is pseudomembranous colitis diagnosed? Diagnosis includes stool tests for Clostridium difficile toxin, colonoscopy, and radiologic studies.
- What is the underlying cause of the disease? The underlying cause is an imbalance in the intestinal microflora caused by antibiotic therapy, which leads to an overgrowth of Clostridium difficile.
- What is the treatment for pseudomembranous colitis? Treatment includes discontinuing antibiotics, prescribing specific antibiotics, as well as probiotics, and, in severe cases, surgical intervention.
- What is the prognosis for patients with pseudomembranous colitis? With proper diagnosis and adequate treatment, the prognosis is usually good, but the risk of recurrence remains high.
